![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2022
Jonigk, Danny; Werlein, Christopher; Acker, Till; Aepfelbacher, Martin; Amann, Kerstin U.; Baretton, Gustavo; Barth, Peter; Bohle, Rainer M.; Büttner, Andreas; Buettner, Reinhard; Dettmeyer, Reinhard; Eichhorn, Philip; Elezkurtaj, Sefer; Esposito, Irene; Evert, Katja; Evert, Matthias; Fend, Falko; Gassler, Nikolaus; Gattenloehner, Stefan; Glatzel, Markus; Göbel, Heike; Gradhand, Elise; Hansen, Torsten; Hartmann, Arndt; Heinemann, Axel; Heppner, Frank L.; Hilsenbeck, Julia; Horst, David; Kamp, Jan C.; Mall, Gita; Maerkl, Bruno; Ondruschka, Benjamin; Pablik, Jessica; Pfefferle, Susanne; Quaas, Alexander; Radbruch, Helena; Röcken, Christoph; Rosenwald, Andreas; Roth, Wilfried; Rudelius, Martina; Schirmacher, Peter; Slotta-Huspenina, Julia; Smith, Kevin; Sommer, Linna; Stock, Konrad; Ströbel, Philipp; Strobl, Stephanie; Titze, Ulf; Weirich, Gregor; Weis, Joachim; Werner, Martin; Wickenhauser, Claudia; Wiech, Thorsten; Wild, Peter; Welte, Tobias; Stillfried, Saskia von und Boor, Peter
(2022):
Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?
In: Virchows Archiv, Bd. 481, Nr. 2: S. 139-159
2020
Sarode, Poonam; Zheng, Xiang; Giotopoulou, Georgia A.; Weigert, Andreas; Kuenne, Carste; Guenther, Stefan; Friedrich, Aleksandra; Gattenloehner, Stefan; Stiewe, Thorsten; Bruene, Bernhard; Grimminger, Friedrich; Stathopoulos, Georgios T.; Pullamsetti, Soni Savai; Seeger, Werner und Savai, Rajkumar
(2020):
Reprogramming of tumor-associated macrophages by targeting beta-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer.
In: Science Advances, Bd. 6, Nr. 23, eaaz6105
2019
Solovey, Maria; Wang, Ying; Michel, Christian; Metzeler, Klaus H.; Herold, Tobias; Goethert, Joachim R.; Ellenrieder, Volker; Hessmann, Elisabeth; Gattenloehner, Stefan; Neubauer, Andreas; Pavlinic, Dinko; Benes, Vladimir; Rupp, Oliver und Burchert, Andreas
(2019):
Nuclear factor of activated T-cells, NFATC1, governs FLT3(ITD)-driven hematopoietic stem cell transformation and a poor prognosis in AML.
In: Journal of Hematology & Oncology, Bd. 12, 72